FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication ...
US FDA clears CMR Surgical's robotic device to assist gall bladder removal
UK-based medical device maker CMR Surgical said on Tuesday that the U.S. Food and Drug Administration has cleared the ...
Medscape12h
FDA Approves Fifth Ustekinumab Biosimilar
The drug is approved for multiple inflammatory conditions and is expected to launch in the first half of 2025.
Major Airline Cancels Meal Service After FDA Flags ‘Food Safety Issue'
A major airline was forced to cancel meal service on hundreds of flights after the Food and Drug Administration (FDA) ...
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer ...
FDA upgrades recall of eggs linked to salmonella to 'serious' health risks. Are there IN cases?
The recall was originally announced Sept. 6 by the Centers for Disease Control and Prevention. It was upgraded Sept. 30 to ...
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
FDA authorizes over-the-counter combined COVID-19 and flu home test
Healgen Scientific's combined COVID-19 and flu test gives people a new way to check what's causing their symptoms, FDA says.
FDA approves first once-weekly drug treatment regimen for hemophilia
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
The Motley Fool8h
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
The FDA earlier this month recognized Lilly’s progress in increasing supply and took the drug off the agency’s shortage list.
Pharmaceutical Technology33m
FDA accepts UroGen’s UGN-102 NDA for bladder cancer treatment
UroGen Pharma has received the NDA acceptance from the US FDA for UGN-102 (mitomycin) to treat bladder cancer.